Published in Pharma Law Weekly, January 15th, 2008
"Each treatment lasted up to 3 days. The first-dose analysis was based on an 8-hour...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.